Current systemic therapies for psoriasis: where are we now?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12894129.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many systemic agents are used in the treatment of psoriasis. They provide good control of psoriasis in the majority of patients and have improved their life quality indices. Frequently, combination therapy is utilized to synergize the efficacy of these medications. Many dermatologists are hesitant in prescribing systemic agents because of their adverse effects. However, such potential toxicities arising from these medications can largely be avoided if proper patient selection and close monitoring are performed.
Medical subject headings
- Dermatologic Agents
- Keratolytic Agents
- Psoriasis